tetracyclic ring system C. This heterocyclic system could
be considered as an hybrid of tetrahydropyrrolo[2,3-b]indole
and tetrahydroimidazo[1,2-a]indole.
mediated hydration of the L-Trp-derived amino nitrile 1.22
However, the treatment of a CH2Cl2 solution of this nitrile
with concentrated H2SO4 [(1:1) H2SO4/CH2Cl2] yielded the
carboxamide 3 as a minor product (15%) along with the
unexpected compound 2a (85%), tautomer of aminonitrile
1, which includes the hexahydropyrrolo[1′,2′,3′:1,9a,9]-
imidazo[1,2-a]indole ring system C. The mass of the [M +
1] ion of the new compound 2a in FAB-HRMS (m/z
326.1884) corresponded to the same molecular formula as
that of the amino nitrile 1, indicating that both compounds
were isomers.
1
With respect to 1, the H NMR spectra of the tetracyclic
tautomer 2a showed the disappearance of the signals corre-
sponding to the indole NH and 2-H protons and the
appearance of a doublet at 5.82 ppm and a triplet at 3.76
ppm for 10c-H and 10b-H protons, respectively. Accordingly,
the 13C NMR spectrum of 2a showed the disappearance of
the indole C2 and C3 signals and the appearance of the
corresponding fusion carbons C10c and C10b at 87.3 and 43.0
ppm, as well as the disappearance of the nitrile carbon (121.6
ppm) of 1, and the presence of the amidine carbon of 2a at
173.9 ppm. The amidine NH did not appear in the 1H NMR,
probably because of a very fast exchange with the solvent.
However, the IR spectrum showed a narrow band at 3311
cm-1 corresponding to the stretching vibration of this NH.
The stereochemistry at the fusion positions C10b and C10c was
established on the basis of the NOE correlations observed
in the 1D NOESY spectra of 2a. Thus, 10c-H showed a NOE
effect with 10b-H, and this proton demonstrated NOE with
the 1-H proton, which did not show NOE with 2-H.
As part of a wide program to develop methodologies for
generating peptidomimetics, we have focused our attention
on the potential of amino acid derived R-amino nitriles as a
source of diversity of privileged scaffolds,17 such as pipera-
zine,18 1,4-benzodiazepine,19 and pyrazino[1,2-c]pyrimidine20
derivatives, via (cyano-methylene)amino pseudopeptides.21
In the course of this research, we were interested in the
tryptophan-derived R-amino carboxamide 3 (Scheme 1) as
Scheme 1. Reactivity of Trp-Derived Amino Nitrile 1 in Acid
Media; Yield of Products 2-4 Shown in Table 1
Searching the literature for precedents on the synthesis of
tetrahydropyrrolo[2,3-b]indole derivatives, we found the
Taniguchi and Hino’s reports on the formation of tryptophan
and tryptamine cyclic tautomers by treatment with acids,23
and several posterior reports on the building of the tetrahy-
dropyrrolo[2,3-b]indole ring system on tryptophan and
tryptamine derivatives by reaction with electrophiles.24 In
these cases, mixtures of diastereoisomers at the pyrroloindole
fusion stereogenic centers are usually obtained for tryptophan
derivatives, in which the product with the endo carboxylate
group is the thermodynamically more stable and the isomer
(19) (a) Herrero, S.; Garc´ıa-Lo´pez, M. T.; Cenarruzabeitia, E.; Del R´ıo,
J.; Herranz, R. Tetrahedron 2003, 59, 4491-4499. (b) Herrero, S.; Garc´ıa-
Lo´pez, M. T.; Herranz, R. J. Org. Chem. 2003, 68, 4582-4585.
(20) Herrero, S.; Salgado, A.; Garc´ıa-Lo´pez, M. T.; Herranz, R.
Tetrahedron Lett. 2002, 43, 4899-4902.
a starting material for the synthesis of spirocyclic compounds.
The access to this carboxamide was planned via acid-
(21) (a) Herranz, R.; Sua´rez-Gea, M. L.; Vinuesa, S.; Garc´ıa-Lo´pez, M.
T. J. Org. Chem. 1993, 58, 5186-5191. (b) Gonza´lez-Mun˜iz, R.; Garc´ıa-
Lo´pez, M. T.; Go´mez-Monterrey, I.; Herranz, R.; Jimeno, M. L.; Sua´rez-
Gea, M. L.; Johansen, N. L.; Madsen, K.; Thøgersen, H.; Suzdak, P. J.
Med. Chem. 1995, 38, 1015-1021. (d) Herrero, S.; Sua´rez-Gea, M. L.;
Gonza´lez-Mun˜iz, R.; Garc´ıa-Lo´pez, M. T.; Herranz, R.; Ballaz, S.; Barber,
A.; Fortun˜o, A.; Del R´ıo, J. Bioorg. Med. Chem. Lett. 1997, 7, 855-860.
(22) Prepared applying a modification of our methodology for the
synthesis of (cyanomethylene)amino pseudopeptides described in ref 21a.
(23) (a) Hino, T.; Taniguchi, M. J. Am. Chem. Soc. 1978, 100, 5564-
5565. (b) Taniguchi, M.; Hino, T. Tetrahedron 1981, 37, 1487-1494.
(24) (a) Crich, D.; Huang, X. J. Org. Chem. 1999, 64, 7218-7223 and
references therein. (b) Depew, K. M.; Marsden, S. P.; Zatorska, D.; Zatorski,
A.; Bornmann, W. G.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121,
11953-11963 and references therein. (c) Caballero, E.; Avendan˜o, C.;
Mene´ndez, J. C. J. Org. Chem. 2003, 68, 6944-6951 and references therein.
(d) Kawahara, M.; Nishida, A.; Nakagawa, M. Org. Lett. 2000, 2, 675-
678.
(15) (a) Numata, A.; Takahashi, C.; Matsushita, T.; Miyamoto, T.; Kawai,
K.; Usami, Y.; Matsumura, E.; Inoue, M.; Ohishi, H.; Shingu, T. Tetra-
hedron Lett. 1992, 33, 1621-1624. (b) Belofsky, G. N.; Anguera, M.;
Jensen, P. R.; Fenical, W.; Kock, M. Chem. Eur. J. 2000, 6, 1355-1360.
(16) (a) Nakao, Y.; Yeung, B. K.; Yoshida, W. Y.; Scheuer, P. J.; Kelly-
Borges, M. J. Am. Chem. Soc. 1995, 117, 8271-8272. (b) Yeung, B. K.;
Nakao, Y.; Kinnel, R. B.; Carney, J. R.; Yoshida, W. Y.; Scheuer, P. J.;
Kelly-Borges, M. J. Org. Chem. 1996, 61, 7168-7173. (c) Nakao, Y.; Kuo,
J.; Yoshida, W. Y.; Kelly, M.; Scheuer, P. J. Org. Lett. 2003, 5, 1387-
1390.
(17) (a) Patchett, A. A.; Nargund, R. P. In Annual Reports in Medicinal
Chemistry; Doherty, A. M., Ed.; Academic Press: San Diego, 2000; Vol.
35, pp 289-298. (b) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem.
ReV. 2003, 103, 893-930.
(18) Herrero, S.; Garc´ıa-Lo´pez, M. T.; Latorre, M.; Cenarruzabeitia, E.;
Del R´ıo, J.; Herranz, R. J. Org. Chem. 2002, 67, 3866-3873.
2642
Org. Lett., Vol. 6, No. 16, 2004